Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC3623 Net-c343

Novel fluorescent RXR antagonist

DCC3624 N-ethylglycine

Lidocaine metabolite, showing antinociceptive effects, inhibiting GlyT1-mediated glycine uptake

627-01-0
DCC3625 N-ethylmaleimide

Modulator of the T1007 site, resulting in rapid activation of this transporter and potentiating KCC2 activity

128-53-0
DCC3626 Neu321

Ligand-efficient inhibitor of Trypanosoma cruzi CYP51 and parasite growth

1426937-35-0
DCC3627 Neu-4854

Novel potent Trypanosoma brucei Inhibitor

DCC3628 Neu617

Novel inhibitor of the growth of protozoan parasites, against T. brucei bloodstream proliferation

1432450-82-2
DCC3629 Neu-730

Novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation

1622300-88-2
DCC3630 Neurodazole

Novel neurogenic inducer for converting pluripotent P19 cells into electrophysiologically active neurons

DCC3631 Neuroprotectant-7

Novel neuroprotectant for Alzheimers disease, showing significant neuroprotection and antioxidative properties, crossing the blood-brain barrier (BBB)

1610504-84-1
DCC3632 Neurotensin(8-13)

The neurotensin active fragment, eliciting behavioral responses typical of clinically used antipsychotic drugs when administered directly to the brain

60482-95-3
DCC3633 Nexturastat A-crbn-12d

Novel potent HDAC6 degrader with promising antiproliferation activity in multiple myeloma (MM) cells

DCC3634 Nfat-133

Inhibitor of NFAT-mediated transcription, leading to the suppression of interleukin-2 expression and T cell proliferation, showing immunosuppressive, antidiabetic, and antitrypanosomal activities

DCC3635 Nf-kappab Inhibitor-2

First-in-class inhibitor of NF-κB signaling pathway by preventing the maturation of a rate-limiting multiprotein complex necessary for IKK activation

DCC3636 N-formyl-met-phe

Neutrophil Dysfunction Test Peptide

22008-60-2
DCC3637 Nfu1827

Novel inhibitor of human cytomegalovirus (HCMV) infection

DCC3638 Ngd 98-2

New generation, topology 2 selective orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist

355836-54-3
DCC3639 Ngd-8243

Novel TRPV1 Antagonist

573678-04-3
DCC3640 Ngd9002

New generation, topology 2 selective corticotropin releasing factor-1 (CRF-1) receptor antagonist

666256-06-0
DCC3641 Ngp1-01

Brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels, acting as chemosensitizer and circumvent the resistance of the plasmodia parasite against chloroquine (CQ) by inhibiting the p-glycoprotein efflux pump and enabling th

33226-57-2
DCC3642 Nh2-bodipy

Novel cell-permeant probe for the super-resolution imaging of the endoplasmic reticulum in live cells

DCC3643 Nh2-nplh2

Novel luciferin analog, enabling both sensitive and highly resolved imaging in vivo

1629640-37-4
DCC3644 Nh2-uamc1110

UAMC1110 Conjugate Linker

Page 1387 / Total 1558 FirstPrevNextLastGoto